Thrilltime Entertainment International Inc (1040368) SEC Filing 20-F Annual report for the fiscal year ending Thursday, July 31, 2003

SEC Filings

1040368 Annual Reports

Advanced Proteome Therapeutics Corp

CIK: 1040368

View differences made from one year to another to evaluate Advanced Proteome Therapeutics Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Proteome Therapeutics Corp.


Assess how Advanced Proteome Therapeutics Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Proteome Therapeutics Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1040368
Form Type: 20-F Annual Report
Accession Number: 0001176256-04-000027
Submitted to the SEC: Wed Jan 28 2004 7:57:14 PM EST
Accepted by the SEC: Thu Jan 29 2004
Period: Thursday, July 31, 2003
Industry: Biological Products No Disgnostic Substances

External Resources:

Bookmark the Permalink: